Franco-Nevada Corporation vs Intuitive Surgical, Inc. — how do they compare? Franco-Nevada Corporation trades at $233.84 (market cap $46.80B), while Intuitive Surgical, Inc. trades at $421.21 (market cap $149.10B). The key difference: Intuitive Surgical, Inc. is far larger — about 3.2× Franco-Nevada Corporation's market cap, and Franco-Nevada Corporation pays a 0.72% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Franco-Nevada Corporation for 0 Days and Intuitive Surgical, Inc. for 84 Days on average.
| FNV | ISRG | |
|---|---|---|
Market Cap | $46.80B | $149.10B |
Volume | 310,692 | 1,732,647 |
Sector | Basic Materials | Health |
52-Week High | $280.82 | $592.85 |
52-Week Low | $183.97 | $332.02 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $45.79B | $143.89B |
Dividend Yield | 0.72% | — |
Signals from Pluang's Aura AI — not financial advice
Franco-Nevada (FNV) trades at $243.85, showing a slight decline of 0.77% over the past day. The stock is positioned neutrally from a technical perspective, with key support near $242 and resistance at $246. Fundamentally, the company exhibits strong profitability with a net income margin of 63.79% and has beaten earnings expectations in two of the last three quarters. Recent news highlights portfolio expansion, including a significant investment in the Bullabulling Gold Project and positive developments regarding the potential restart of the Cobre Panama mine.
The outlook for FNV is supported by analyst consensus, with a price target of $275 suggesting potential upside. Key opportunities include revenue growth from new projects and high profit margins. Risks involve execution on new investments, commodity price volatility, and geopolitical factors affecting mining operations. The balanced analyst rating split indicates cautious optimism for future performance.
Intuitive Surgical (ISRG) trades at $420.24, down 1.73% on the day, but maintains strong fundamentals with consistent earnings beats and robust revenue growth. The company reported $10.06B in 2025 revenue with 28.45% net margins, while technical indicators show a bullish trend with support at $414. Recent news highlights international expansion in India and Japan to offset China weakness.
ISRG presents a compelling investment case with 70% analyst buy ratings and a $480.78 price target offering 14% upside. Key risks include competitive pressures in robotic surgery and procedure growth concerns, but the company's market leadership and recurring revenue model support long-term growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Franco-Nevada Corporation is a royalty and streaming company that finances mining and energy projects in exchange for royalty payments or the right to purchase output at set prices, holding a diversified portfolio across Precious Metals, Other Mining, and Energy (oil, gas, and natural gas liquids).
Read more on FNV →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →